The universal soldier: enzymatic and non-enzymatic antioxidant functions of serum albumin

DA Belinskaia, PA Voronina, VI Shmurak, MA Vovk… - Antioxidants, 2020 - mdpi.com
As a carrier of many biologically active compounds, blood is exposed to oxidants to a
greater extent than the intracellular environment. Serum albumin plays a key role in …

Liver-derived metabolites as signaling molecules in fatty liver disease

U Keles, JR Ow, KB Kuentzel, LN Zhao… - Cellular and Molecular …, 2023 - Springer
Excessive fat accumulation in the liver has become a major health threat worldwide.
Unresolved fat deposition in the liver can go undetected until it develops into fatty liver …

Mechanistic insights of soluble uric acid-induced insulin resistance: Insulin signaling and beyond

W Yu, D Xie, T Yamamoto, H Koyama… - Reviews in Endocrine and …, 2023 - Springer
Hyperuricemia is a metabolic disease caused by purine nucleotide metabolism disorder.
The prevalence of hyperuricemia is increasing worldwide, with a growing trend in the …

[HTML][HTML] URAT1-selective inhibition ameliorates insulin resistance by attenuating diet-induced hepatic steatosis and brown adipose tissue whitening in mice

Y Tanaka, T Nagoshi, H Takahashi, Y Oi, A Yoshii… - Molecular …, 2022 - Elsevier
Objective Accumulating evidence indicates that high uric acid (UA) is strongly associated
with obesity and metabolic syndrome and drives the development of nonalcoholic fatty liver …

The dysregulation of immune cells induced by uric acid: mechanisms of inflammation associated with hyperuricemia and its complications

D Li, S Yuan, Y Deng, X Wang, S Wu, X Chen… - Frontiers in …, 2023 - frontiersin.org
Changes in lifestyle induce an increase in patients with hyperuricemia (HUA), leading to
gout, gouty arthritis, renal damage, and cardiovascular injury. There is a strong inflammatory …

[HTML][HTML] Hepatic accumulation of hypoxanthine: a link between hyperuricemia and nonalcoholic fatty liver disease

P Toledo-Ibelles, R Gutiérrez-Vidal… - Archives of medical …, 2021 - Elsevier
Background An elevated level of plasma uric acid has been widely recognized as a risk
factor for non-alcoholic fatty liver disease (NAFLD), where oxidative stress and inflammation …

An update on the chemokine system in the development of NAFLD

N Nagata, G Chen, L Xu, H Ando - Medicina, 2022 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
world. Sustained hepatic inflammation is a key driver of the transition from simple fatty liver …

Investigation of the inhibition mechanism of xanthine oxidoreductase by oxipurinol: A computational study

Y Maghsoud, C Dong, GA Cisneros - Journal of Chemical …, 2023 - ACS Publications
Xanthine oxidoreductase (XOR) is an enzyme found in various organisms. It converts
hypoxanthine to xanthine and urate, which are crucial steps in purine elimination in humans …

[HTML][HTML] Friend or foe? An unrecognized role of uric acid in cancer development and the potential anticancer effects of uric acid-lowering drugs

S Mi, L Gong, Z Sui - Journal of Cancer, 2020 - ncbi.nlm.nih.gov
In recent years, metabolic syndrome (Mets) has been a hot topic among medical scientists.
Mets has an intimate relationship with the incidence and development of various cancers. As …

Targets and mechanisms of dietary anthocyanins to combat hyperglycemia and hyperuricemia: A comprehensive review

Y Yang, J Zhang, Q Zhou - Critical Reviews in Food Science and …, 2022 - Taylor & Francis
Hyperglycemia and hyperuricemia are both metabolic disorders related to excessive amount
of metabolites in blood, which are considered as high risk factors for the development of …